<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serologic reactivity against EBV-infected lines was assayed in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> (n = 4) or the <z:e sem="disease" ids="C0001857" disease_type="Disease or Syndrome" abbrv="">AIDS related complex</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-RC) (n = 46) residing in Argentina </plain></SENT>
<SENT sid="1" pm="."><plain>Anti-VCA serology was comparable to that of controls </plain></SENT>
<SENT sid="2" pm="."><plain>However sera from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-RC could induce antibody dependent cell mediated cytotoxicity (ADCC) to EBV-infected cell lines (P3HRIK and Raji) </plain></SENT>
<SENT sid="3" pm="."><plain>ADCC activity could be recovered in the high molecular weight fractions of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-RC sera </plain></SENT>
<SENT sid="4" pm="."><plain>ADCC was observed in sera with high levels of <z:chebi fb="77" ids="46793">PEG</z:chebi> precipitable material (<z:chebi fb="77" ids="46793">PEG</z:chebi>-pp) but was unrelated to the presence of complement-fixing immune complexes (Clq-F) or to anti-VCA titers </plain></SENT>
<SENT sid="5" pm="."><plain>Fc receptor (FcR) bridging between target cells FcR and effector cells FcR may play a role in the outcome of total ADCC </plain></SENT>
</text></document>